CLINICAL SIGNIFICANCE OF NEUROPEPTIDE LEVELS IN EARLY DIAGNOSIS OF PRIMARY HEADACHE DISORDERS

Authors

  • Kamoliddin Allanazarov Department of Neurology, Tashkent State Medical University, Uzbekistan Author

Keywords:

Primary headache disorders are among the most common neurological conditions worldwide and represent a major cause of disability and reduced quality of life [1]. Migraine, tension-type headache, and cluster headache are the most prevalent forms and account for a substantial proportion of neurological consultations [2].

Abstract

Background: Primary headache disorders, including migraine, tension-type headache, and cluster headache, are among the most prevalent neurological conditions. Early diagnosis remains challenging due to overlapping clinical features. Neuropeptides are increasingly recognized as key mediators in headache pathophysiology and potential diagnostic biomarkers. Objective: To evaluate the clinical significance of neuropeptide levels in the early diagnosis of primary headache disorders. Methods: A clinical observational study included patients with primary headache disorders and a control group of healthy individuals. Serum levels of neuropeptides, including calcitonin gene-related peptide (CGRP), substance P, and vasoactive intestinal peptide (VIP), were measured. Clinical and laboratory findings were analyzed to assess diagnostic value and correlations with clinical parameters. Results: Patients with primary headache disorders demonstrated significantly elevated levels of CGRP and substance P compared to controls (p < 0.01). The highest CGRP levels were observed in migraine patients, while substance P was elevated across all headache types. VIP levels showed moderate variation. Significant correlations were found between CGRP levels and headache intensity (r = 0.63, p < 0.001), as well as frequency of attacks (r = 0.58, p < 0.01). Diagnostic analysis revealed high sensitivity and specificity of CGRP in distinguishing migraine from other headache types. Conclusion: Neuropeptides, particularly CGRP, have significant diagnostic value in the early identification of primary headache disorders. Their use as biomarkers may improve diagnostic accuracy and guide personalized treatment strategies.

References

1.Mirzaeva D, Khosilova R. Comparative evaluation of the diagnostic performance of radiomics-based ultrasound analysis in the differential diagnosis of ovarian cysts.

2.Qarshiboyeva N, Tolibov D, Mirzaeva D, Das S. Structural brain changes and cognitive deficits in ischemic stroke: MRI and neurocognitive correlations. Journal of the Neurological Sciences. 2025 Dec 1;480.

3.Mamarizaev I, Ikhtiyarova G, Dustova N, Rakhmanova N, Mirzaeva D, Nishanova F, Karimova L, Abdurahmonov A. Comparative analysis of maternal and fetal outcomes in preeclampsia with and without HELLP syndrome in uzbek women: a retrospective cohort study. Revista Latinoamericana de Hipertensión. 2025 Dec 1;20(11).

4.Usmonova DI, Mirzaeva DB, Das S. PREDICTIVE FACTORS IN WOMEN WITH RECURRENT ABNORMAL UTERINE BLEEDING AND ITS IMPACT ON QUALITY OF LIFE.

5.Шокиров Ш, Толибов Д. ДИФФЕРЕНЦИАЛЬНАЯ ДИАГНОСТИКА СОМАТОФОРМНОЙ ВЕГЕТАТИВНОЙ ДИСФУНКЦИИ И ОРГАНИЧЕСКИХ ЗАБОЛЕВАНИЙ НА ОСНОВЕ ПРОФИЛЯ НЕЙРОЭНДОКРИННЫХ БИОМАРКЕРОВ. Универсальный индекс библиотеки молодых ученых. 2025 Oct 20;3(38):90-2.

6.Shokirov S, Tolibov D. THE ROLE OF NEUROENDOCRINE BIOMARKERS IN THE DIAGNOSIS OF SOMATOFORM AUTONOMIC DYSFUNCTION: A SYSTEMATIC REVIEW. InInternational Conference on Health & Technology 2025 Oct 19 (Vol. 1, No. 1, pp. 75-77).

7.Tolibov DS, qizi Qarshiboyeva NI, Yusupov AU. O ‘ZBEKISTONDA ISHEMIK INSULTGA CHALINGAN YOSH BEMORLARNING ETIOLOGIK VA XAVF OMILLARI BO’YICHA KLINIK PROFILI. Медицинский журнал молодых ученых. 2025 Jun 5(14 (06)):15-20.

8.Qarshiboyeva N, Tolibov D, Ismatov A, Abdurasulova N. Study of the Incidence and Prevalence of Depression after Parkinson's disease, Ischemic stroke, and Migraine in the population of Uzbekistan. Parkinsonism & Related Disorders. 2025 May 1;134.

9.Tolibov D, Das S. REHABILITATION OF BELL’S PALSY PATIENTS USING NERVE MUSCLE STIMULATOR DEVICES. REHABILITATION. 2025 May;3(5).

10.Tolibov DS, Abdurasulova NA, Qarshiboyeva N. The Impact of Autonomic Disorders in Parkinson's Disease and the Importance of Early Diagnosis. Parkinsonism & Related Disorders. 2025 May 1;134.

11.Qarshiboyeva N, Tolibov D, Ismatov A, Abdurasulova N. Study of the Incidence and Prevalence of Depression after Parkinson's disease, Ischemic stroke, and Migraine in the population of Uzbekistan. Parkinsonism & Related Disorders. 2025 May 1;134.

12.Tolibov DS, Qarshiboyeva NI, Yusupov AU. O’TKIR INSULT BILAN KASALLANGAN BEMORLARDA KOGNITIV FAOLIYATNI BAHOLASH. Вестник Ассоциации Пульмонологов Центральной Азии. 2025;15(10):310-5.

13.Salokhiddinov Sr M, Kumar Sr D, Singh Sr D, Ismailova M, Gandhamal A. Automated quantification of lateral and medial temporal lobe volumes for improved diagnosis of early Alzheimer's disease. Alzheimer's & Dementia. 2025 Dec;21:e102485.

14.Рахимбаева ГС, Газиева ШР, Атаниязов МК, Муратов ФХ, Толипов ДС, Шодиев УД. Особенности лечения и реабилитация больных, перенесших COVID-19, с ишемическим инсультом. Журнал неврологии и психиатрии им. СС Корсакова. 2023;123(3-2):76-84.

15.Mengliyeva D, Shomaqsudova M, Mirzaeva D, Okboev A, Aripova K, Jumayev I, Makhmudova G, Oygul N, Kadirov T, Rashidov N, Radjabov N. Fe3O4-Polyvinylpyrrolidone-Decorated on Graphene Oxide Nanosheets for Fast Detection of Trace Protein. Journal of Nanostructures. 2025 Oct 1;15(4):2071-83.

16.Mirzaeva D, Nosirova S. COMPARATIVE ANALYSIS OF CONTRACEPTIVE INTENTIONS IN WOMEN AFTER CHILDBIRTH. Modern Science and Research. 2025;4(3):1699-706.

17.Mirzaeva DB, Sharodiya D. Diagnostic and prognostic value of platelet indices as a potential biomarker in preeclampsia: a case-control study in a maternity hospital at Tashkent. International Journal of Medical Sciences And Clinical Research. 2025 Feb 28;5(02):95-101.

18.Das S, Mirzaeva D. Prevalence and hematological profiles of pregnancy anemia: extended cross-sectional analysis in a tertiary care center in Tashkent. PREVALENCE. 2025 May;3(5).

19.Mirzaeva D, Tolibov D, Dwivedi K. Diagnostic Performance of ROMA and Biomarkers in Ovarian Cancer: A Systematic Review of Sensitivity, Specificity, and Menopausal Influence. Indian Journal of Medical and Paediatric Oncology. 2026 Feb 16.

Downloads

Published

2026-05-15